We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Siemens Partners with Hamamatsu to Expand Into Digital Pathology in Americas and Europe

By LabMedica International staff writers
Posted on 09 Mar 2023
Print article
Image: In the US, C13220-01MD NanoZoomer S360MD Slide scanner system is intended for in vitro diagnostic use (Photo courtesy of Hamamatsu)
Image: In the US, C13220-01MD NanoZoomer S360MD Slide scanner system is intended for in vitro diagnostic use (Photo courtesy of Hamamatsu)

Today, digital pathology is at a tipping point, with the evolution from glass to digital already transforming standards of care. This transformation is being driven by the technological combination of high-speed, high-resolution imaging; trusted medical data storage; fast, secure data transmission; and intuitive, inter-operable workflows with continual improvements in AI.

Siemens Healthineers (Erlangen, Germany) has entered into a multi-year distribution agreement with Hamamatsu (Shizuoka, Japan), under which Hamamatsu will provide NanoZoomer whole slide scanners to support Siemens’ expansion into digital pathology in the Americas and Europe.

Hamamatsu, a leading manufacturer of photonics devices, including whole slide scanners for digital pathology, has more than 60 years of experience in photonics engineering. The company has developed NanoZoomer scanners which are renowned for their image quality, reliability, and ease of use. Siemens has decades of experience in diagnostics, enterprise imaging, and healthcare IT. The partnership with Hamamatsu NanoZoomer whole slide scanners will help Siemens close the gap between radiology and pathology to achieve full potential of digital operations in patient care.

"This partnership between Hamamatsu and Siemens Healthineers will create tremendous value for laboratories and healthcare ecosystems," said, Fumio Iwase, Executive Officer, Division Director, Systems Division at Hamamatsu Photonics K.K., who believes that integrating complex hardware and software solutions into pathologists' workflow is critical to maximizing the potential of digital pathology in clinical environments. "Together, we will help laboratories across healthcare systems adopt digital pathology by seamlessly integrating pathologists' workflow with hardware to provide the utmost patient care."

"We now complement our portfolio for digital pathology with the products and expertise of Hamamatsu," added Christian Zapf, Head of Digital & Automation at Siemens Healthineers. "Together with our strong Syngo Carbon portfolio in enterprise imaging IT, we can now help our customers to comprehensively gain the benefits of a digital transformation in digital pathology."

Related Links:
Siemens Healthineers 
Hamamatsu 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Researchers have found a way to spot the debilitating disease Alzheimer\'s before it develops into dementia (Photo courtesy of 123RF)

Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia

Alzheimer’s disease is well known for its slow development over many years, which typically leads to treatment interventions only after the disease has advanced to stages where it may be nearly impossible... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ASTar System has received US FDA 510(k) clearance (Photo courtesy of Q-linea AB)

Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections

Sepsis affects up to 50 million people globally each year, with bacteraemia, formerly known as blood poisoning, being a major cause. In the United States alone, approximately two million individuals are... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more